GlassScriptPhysician profile
Holly D Smith
NPI 1720006935
$3,105.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2021: $2,362 · 2022: $600 · 2024: $42.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,122.76 | 2021 | |
| Artivion, INC. | $965.42 | 2021-2022 | |
| Medtronic, INC. | $256.50 | 2021-2022 | |
| Angiodynamics, INC. | $182.69 | 2021 | |
| Bard Peripheral Vascular, INC. | $133.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2022 | |
| Abbott Laboratories | $119.82 | 2021 | |
| Inari Medical, INC. | $56.01 | 2021 | |
| Sanofi Pasteur INC. | $42.94 | 2024 | |
| Glaxosmithkline, LLC. | $39.57 | 2019 | |
| Genentech USA, INC. | $24.94 | 2019 | |
| Grifols USA, LLC | $12.53 | 2019 | |
| Viiv Healthcare Company | $12.21 | 2019 | |
| Amgen INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.